Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIZATRIPTAN vs ROMOSOZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIZATRIPTAN vs ROMOSOZUMAB: Safety Overview

Metric RIZATRIPTAN ROMOSOZUMAB
Total FAERS Reports 2,896 434
Deaths Reported 68 48
Death Rate 2.3% 11.1%
Hospitalizations 479 81
Average Patient Age 44.6 yrs 69.1 yrs
% Female Patients 77.2% 94.5%
FDA Approval Date Apr 14, 2023 N/A
Manufacturer Panacea Biotec Limited Amgen, Inc
Route ORAL SUBCUTANEOUS
Marketing Status Discontinued N/A